Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 18, 2023, titled "Stelis Biopharma s flagship facility receives EIR from the USFDA on the successful closure of its inspection specific to Drug-Device Combination Products".
Strides Pharma Science Ltd Press Release Jan 18 2023
Filed with NSE · · 3 pages · English
Release
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release Dec 28 2022
- Press Release Dec 22 2022
- Press Release Nov 18 2022
- Press Release Nov 14 2022
- Share Warrants
Later from Strides Pharma Science
- Press Release Jan 20 2023
- Earnings Update_Q3FY23
- Earnings Update_Q2FY23
- Strides Pharma Science Ltd Press Release Feb 24 2023
- Strides Pharma Science Ltd Press Release May 03 2023
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science